Israel Englander’s Zosano Pharma Corporation ZSAN Stock Holding History

Israel Englander’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,043	Closed	-$34K	–	8021
2021 Q4	$34K	Sell	2,043 -183	-8%	-$3.86K	﹤0.01%	6552
2021 Q3	$56K	Buy	2,226 +257	+13%	+$6.67K	﹤0.01%	6560
2021 Q2	$65K	Buy	+1,969	New	+$63.5K	﹤0.01%	6339
2018 Q3	–	Sell	-337	Closed	-$48K	–	4418
2018 Q2	$48K	Sell	337 -3,228	-91%	-$486K	﹤0.01%	3708
2018 Q1	$629K	Buy	+3,565	New	+$1.19M	﹤0.01%	2932
2015 Q3	–	Sell	-18	Closed	-$90K	–	3839
2015 Q2	$90K	Sell	18 -23	-56%	-$142K	﹤0.01%	3186
2015 Q1	$287K	Buy	+41	New	+$308K	﹤0.01%	3066

Other funds holding ZSAN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CDIA

Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Israel Englander's ZSAN Position: Q1 2022 in Review

Israel Englander sold out of Zosano Pharma Corporation (ZSAN) in Q1 2022, closing a stake of 2,043 shares — an estimated $34K sold.

Israel Englander first reported a position in ZSAN in Q1 2015 and held it in 7 quarters. The position peaked at $629K in Q1 2018. 30 funds tracked by Wall St. Rank hold ZSAN as of Q1 2022.

Israel Englander reported no remaining Zosano Pharma Corporation position as of Q1 2022 after selling out during the quarter.
Israel Englander sold 2,043 Zosano Pharma Corporation shares in Q1 2022, an estimated $34K.
Israel Englander first reported a position in Zosano Pharma Corporation in Q1 2015 and held it in 7 quarters.
Israel Englander's Zosano Pharma Corporation position peaked at $629K in Q1 2018.
30 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2022.

Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.